Short answer · Medically reviewed summary · Last updated: 2026-05-08
TNF Receptor Associated Periodic Syndrome (TRAPS) was first identified in 1982 as a "familial Hibernian fever," characterized by long-lasting, recurrent fevers and localized inflammation. Since its discovery, medical understanding of TNF Receptor Associated Periodic Syndrome has evolved from a clinical observation of an Irish kindred to a well-defined autosomal dominant autoinflammatory disorder caused by mutations in the TNFRSF1A gene. When was TNF Receptor Associated Periodic Syndrome first described? The condition was originally described in 1982 by Williamson and colleagues, who reported a family of Irish-Scottish descent exhibiting recurrent fevers and abdominal pain, initially naming the disorder "familial Hibernian fever." For years, it was misdiagnosed as periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome or other hereditary periodic fevers. How did genetics change our understanding of TRAPS? The major turning point occurred in 1999, when researchers identified that TNF Receptor Associated Periodic Syndrome is caused by mutations in the TNFRSF1A gene, which encodes the 55-kDa TNF receptor.
What is the history of TNF Receptor Associated Periodic Syndrome?
History of TNF Receptor Associated Periodic Syndrome: when and how it was discovered, and the milestones in research since, medically reviewed.
TNF Receptor Associated Periodic Syndrome (TRAPS) was first identified in 1982 as a "familial Hibernian fever," characterized by long-lasting, recurrent fevers and localized inflammation. Since its discovery, medical understanding of TNF Receptor Associated Periodic Syndrome has evolved from a clinical observation of an Irish kindred to a well-defined autosomal dominant autoinflammatory disorder caused by mutations in the TNFRSF1A gene.
When was TNF Receptor Associated Periodic Syndrome first described?
The condition was originally described in 1982 by Williamson and colleagues, who reported a family of Irish-Scottish descent exhibiting recurrent fevers and abdominal pain, initially naming the disorder "familial Hibernian fever." For years, it was misdiagnosed as periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome or other hereditary periodic fevers.
How did genetics change our understanding of TRAPS?
The major turning point occurred in 1999, when researchers identified that TNF Receptor Associated Periodic Syndrome is caused by mutations in the TNFRSF1A gene, which encodes the 55-kDa TNF receptor. This breakthrough transformed the classification of the disease from an idiopathic fever to a recognized autoinflammatory condition, allowing for targeted molecular testing.
What are the major milestones in treatment?
Historically, patients with TNF Receptor Associated Periodic Syndrome faced few effective options, often relying on corticosteroids. The understanding of the disease as an autoinflammatory process led to the use of biologic therapies that specifically target the TNF pathway:
- Etanercept: Often the first-line biologic treatment to manage inflammation in TNF Receptor Associated Periodic Syndrome.
- IL-1 Inhibitors: Medications like canakinumab have become essential for patients who do not respond to TNF-alpha inhibitors.
- Amyloidosis Prevention: Early intervention is now prioritized to prevent secondary AA amyloidosis, a severe, life-threatening complication.
How has patient advocacy shaped the narrative?
Early patients often faced medical skepticism due to the rarity of the disease. Today, global awareness has grown through platforms like DiseaseMaps.org, where individuals with TNF Receptor Associated Periodic Syndrome connect to share experiences. This community-driven data helps researchers better understand the heterogeneous nature of the condition, which affects an estimated 1 in 1,000,000 people globally.
Next steps
- Consult with a rheumatologist or immunologist specializing in autoinflammatory diseases.
- Request genetic testing for TNFRSF1A mutations to confirm a diagnosis.
- Join the DiseaseMaps.org community to connect with other patients and caregivers.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): TNF Receptor Associated Periodic Syndrome
- Orphanet: TNF receptor-associated periodic syndrome
- OMIM (Online Mendelian Inheritance in Man): TNFRSF1A-associated periodic syndrome
- PubMed: "The discovery of the TNFRSF1A mutations in Familial Hibernian Fever" (McDermott et al., 1999)
